drugset / Trial / NCT04143282

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

NCT04143282 ↗

Phase 2 Completed 250 enrolled Hager salah el din
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to determine the effect of metformin along with standard cancer treatment, and its effect on the prognosis of the metastatic breast in non-diabetic patients.

Timeline

Start
2019-10-20
Primary completion
2020-04-20
Completion
2020-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1 g —

Indications